Effects of Eldecalcitol and/or Raloxifene on insulin sensitivity and carotid intima-media thickness in postmenopausal woman.
Not Applicable
Recruiting
- Conditions
- Postmenopausal osteoporosis
- Registration Number
- JPRN-UMIN000012269
- Lead Sponsor
- Kyushu-University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
The following subjects will be excluded from the study: 1.Pregnants women, women suspected of being pregnant, or lactating women 2.Patients who have been diagnosed or history of thromboembolism (including deep vein thrombosis, pulmonary embolism, retinal vein occlusion) 3.Patients who is a long term and immovable 4.Patients who is an antiphospholipid syndrome 5.Patients who have a hypersensitivity to Raloxifene or Eldecalcidol 6.Patients who are treated with bisphosphonates, or within 3 month after the suspension of administration 7.Patients whom the principle investigators or other investigators consider unsuitable
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method